Evidence map›Paper›PMID 40710109›Full record

ArticleBiosensors2025

An Automated Microfluidic Platform for In Vitro Raman Analysis of Living Cells.

Illya Klyusko, Stefania Scalise, Francesco Guzzi, Luigi Randazzini, Simona Zaccone, Elvira Immacolata Parrotta, Valeria Lucchino, Alessio Merola, Carlo Cosentino, Ulrich Krühne and 5 more

Abstract read
In one paragraph

Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Illya KlyuskoDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.ORCID 0009-0002-5459-496X
Stefania ScaliseDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0001-6979-1486
Francesco GuzziDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0003-3004-7806
Luigi RandazziniDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.
Simona ZacconeDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.
Elvira Immacolata ParrottaDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0001-8145-3623
Valeria LucchinoDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0002-7350-3835
Alessio MerolaDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0002-8728-2084
Carlo CosentinoDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0001-5768-1829
Ulrich KrühneDepartment of Chemistry and Biochemical Engineering, Technical University of Denmark, DK-2800 Kgs. Lyhgby, Denmark.ORCID 0000-0001-7774-7442
Isabella AquilaDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0002-2481-6050
Giovanni CudaDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0001-6313-1866
Enzo Di FabrizioDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.
Patrizio CandeloroDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0001-6156-887X
Gerardo PerozzielloDepartment of Experimental and Clinical Medicine, University of Catanzaro, Germaneto, 88100 Catanzaro, Italy.

Funding

European Union "NextGenerationEU" through the National Plan of Recovery and Resilience (PNRR), which financed the project PRIN PNRR titled "Automated Microfluidic Platforms for Innovative Cell Screenings" CUP: F53D23008830001; project code: P2022NNSFF
6 · The paper itself

Abstract

We present a miniaturized, inexpensive, and user-friendly microfluidic platform to support biological applications. The system integrates a mini-incubator providing controlled environmental conditions and housing a microfluidic device for long-term cell culture experiments. The incubator is designed to be compatible with standard inverted optical microscopes and Raman spectrometers, allowing for the non-invasive imaging and spectroscopic analysis of cell cultures in vitro. The microfluidic device, which reproduces a dynamic environment, was optimized to sustain a passive, gravity-driven flow of medium, eliminating the need for an external pumping system and reducing mechanical stress on the cells. The platform was tested using Raman analysis and adherent tumoral cells to assess proliferation prior and subsequent to hydrogen peroxide treatment for oxidative stress induction. The results demonstrated a successful adhesion of cells onto the substrate and their proliferation. Furthermore, the platform is suitable for carrying out optical monitoring of cultures and Raman analysis. In fact, it was possible to discriminate spectra deriving from control and hydrogen peroxide-treated cells in terms of DNA backbone and cellular membrane modification effects provoked by reactive oxygen species (ROS) activity. The 800-1100 cm

Indexed as

Lab-On-A-Chip DevicesSpectrum Analysis, RamanCell ProliferationHumansHydrogen PeroxideOxidative StressReactive Oxygen SpeciesHydrogen PeroxideReactive Oxygen Speciescancer cellscell culturingin vitro culturingmicrofluidicsmicrofluidic screening devicesmini-incubatoroptical imagingRaman spectroscopy

Identifiers

PMID40710109
PMCPMC12293637

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.